Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anteneh Nigussie Sheferaw
Observed name:
A.N. Sheferaw
Institution:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Observed institution:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
ORCID:
0009-0004-5299-1464
Observed ORCID:
0009-0004-5299-1464
OpenAlex ID:
A5096197260
From MASLD to HCC: What's in the middle?
2024
·
Alessia Provera
, Cristina Vecchio
, et al.
·
Heliyon
·
27
Vegetal oil-based ketogenic diet improves inflammation and fibrosis in experimental metabolic dysfunction-associated steatohepatitis
2025
·
Alessia Provera
, Naresh Naik Ramavath
, et al.
·
Frontiers in Immunology
·
10
PDF
ICOSL: more than a trigger of ICOS function
2025
·
Ian Stoppa
, Alessia Provera
, et al.
·
Cell Communication and Signaling
·
5
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound Healing
2024
·
Foteini Christaki
, Amirabbas Ghasemi
, et al.
·
International Journal of Molecular Sciences
·
3
PDF
When the Liver Flares: Inflammatory and Immunometabolic Mechanisms Driving the Transition from MASLD to MASH
2026
·
Cristina Vecchio
, Anteneh Nigussie Sheferaw
, et al.
·
Inflammation
·
1
Dietary Fructose Alters Duodenal Mucin Glycosylation and Mucus Production in High-Fat Diet-Fed Mice
2026
·
Donatella Mentino
, Alessia Provera
, et al.
·
International Journal of Molecular Sciences
·
1
Letter to the Editor: Xietu Hemu prescription: A novel therapeutic strategy for obesity and metabolic dysfunction-associated steatotic liver disease?
2026
·
Alessia Provera
, Anteneh Nigussie Sheferaw
, et al.
·
World Journal of Hepatology
PDF
297P Effects of ICOS-Fc on tumour spheroid growth and gene expression in a 3D breast cancer model
2025
·
F. Christaki
, A. Ghasemi
, et al.
·
Immuno-Oncology Technology
Show more works
View as search
Works count:
8
Citation count:
47
H-index:
3
I10-index:
2
Year
Topic
Type